Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jul 27:8:16.
doi: 10.1186/1744-859X-8-16.

Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review

Konstantinos N Fountoulakis  1 , Eduard Vieta
Affiliations

Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review

Konstantinos N Fountoulakis et al. Ann Gen Psychiatry. .

Abstract

Background: The current article is a systematic review concerning the efficacy and safety of aripiprazole in the treatment of bipolar disorder.

Methods: A systematic Medline and repositories search concerning the usefulness of aripiprazole in bipolar disorder was performed, with the combination of the words 'aripiprazole' and 'bipolar'.

Results: The search returned 184 articles and was last updated on 15 April 2009. An additional search included repositories of clinical trials and previous systematic reviews specifically in order to trace unpublished trials. There were seven placebo-controlled randomised controlled trials (RCTs), six with comparator studies and one with add-on studies. They assessed the usefulness of aripiprazole in acute mania, acute bipolar depression and during the maintenance phase in comparison to placebo, lithium or haloperidol.

Conclusion: Aripiprazole appears effective for the treatment and prophylaxis against mania. The data on bipolar depression are so far negative, however there is a need for further study at lower dosages. The most frequent adverse effects are extrapyramidal signs and symptoms, especially akathisia, without any significant weight gain, hyperprolactinaemia or laboratory test changes.

PubMed Disclaimer

References

    1. Lange F. De vigtigste Sindssygdomme (the most important pychiatric disorders) Copenhagen, Denmark: Gyldendal; 1894.
    1. Cade J. Lithium salts in the treatment of psychotic excitement. Med J Aust. 1949;36:349–352. - PubMed
    1. Cade J. The story of lithium. In: Ayd F, Blackwell B, editor. Discoveries in biological psychiatry. Philadelphia, PA: Lippincott; 1970.
    1. Bech P. The full story of lithium. A tribute to Mogens Schou (1918–2005) Psychother Psychosom. 2006;75:265–269. doi: 10.1159/000093947. - DOI - PubMed
    1. Schou M, Juel-Nielsen N, Stromgren E, Voldby H. The treatment of manic psychosis by the administration of lithium salts. J Neurol Neurosurg Psychiatry. 1954;17:250–260. doi: 10.1136/jnnp.17.4.250. - DOI - PMC - PubMed